Consistent with the GABAergic-glutamatergic modulation of GABA neurotransmission, Woo and colleagues [345] showed a decreased density of GAD67 mRNA–containing neurons in BD patients and an even higher reduction of cells co-expressing the NMDA NR(2A) subunit [346]. Here, GAD1 is linked to Behcet disease.